VivoSeq
Other

Pain Management

5

Pipeline Programs

23

Active Trials

6

Companies Involved

Pain Management is an early-stage landscape with 5 programs across 6 companies. The most active players are Javelin Pharmaceuticals, Eli Lilly, Milestone Pharmaceuticals Inc.. 1 program is in Phase 3.

Pipeline Metrics

Competitive Density

43/100

Pipeline Velocity

36/100

Mech. Concentration

33/100

Completion Rate

75/100

Attrition Rate

15/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

105

clinical trials

Completed50 · 48%
Unknown status15 · 14%
Recruiting12 · 11%
Withdrawn9 · 9%
Terminated7 · 7%
Not yet recruiting7 · 7%
Other5 · 5%

Trial Activity

105 trials

Celecoxib for ENT Pain Management
Recruiting·UUniversity of Wisconsin, Madison·Phase 2·NCT06505187·84 enrolled
Pain Management With Virtual Reality Hypnosis
Recruiting··N/A·NCT06502457·142 enrolled
Enantyum® IV Versus Piroxen® IM in Emergency Pain Management
Recruiting··Phase 3·NCT06404177·300 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)